Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isenberg

Showing results (261-270 of 286) with videos related to

Pageof 29
Sort By:
Arthritis and Rheumatism|March 1, 1996
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosusD Gladman, E Ginzler, C Goldsmith, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
Annals of the Rheumatic Diseases|June 5, 2007
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort studyS Bernatsky, L Joseph, J-F Boivin, et al.
Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.
Arthritis and Rheumatism|October 7, 2005
Race/ethnicity and cancer occurrence in systemic lupus erythematosusS Bernatsky, J F Boivin, L Joseph, et al.
Lupus|August 31, 2007
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Arthritis and Rheumatism|February 2, 2008
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Pageof 29

Showing results (261-270 of 286) with videos related to

Sort By:
Pageof 29
Arthritis and Rheumatism|March 1, 1996
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosusD Gladman, E Ginzler, C Goldsmith, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
Annals of the Rheumatic Diseases|June 5, 2007
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort studyS Bernatsky, L Joseph, J-F Boivin, et al.
Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.
Arthritis and Rheumatism|October 7, 2005
Race/ethnicity and cancer occurrence in systemic lupus erythematosusS Bernatsky, J F Boivin, L Joseph, et al.
Lupus|August 31, 2007
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Arthritis and Rheumatism|February 2, 2008
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Pageof 29